Surgical Planning Laboratory - Brigham & Women's Hospital - Boston, Massachusetts USA - a teaching affiliate of Harvard Medical School

Surgical Planning Laboratory

The Publication Database hosted by SPL

All Publications | Upload | Advanced Search | Gallery View | Download Statistics | Help | Import | Log in

Reviewing the Ketamine Model for Schizophrenia

UCLA Center for Autism Research and Treatment (CART), University of California, Los Angeles, CA, USA.
Publication Date:
J Psychopharmacol
Volume Number:
Issue Number:
J Psychopharmacol. 2014 Apr;28(4):287-302.
PubMed ID:
Ketamine, N-methyl-D-aspartate receptor, Glutamate, Schizophrenia
Appears in Collections:
U54 EB005149/EB/NIBIB NIH HHS/United States
R41 NS081792/NS/NINDS NIH HHS/United States
Generated Citation:
Frohlich J., Van Horn J.D. Reviewing the Ketamine Model for Schizophrenia. J Psychopharmacol. 2014 Apr;28(4):287-302. PMID: 24257811. PMCID: PMC4133098.
Downloaded: 1203 times. [view map]
Paper: Download, View online
Export citation:
Google Scholar: link

The observation that antagonists of the N-methyl-D-aspartate receptor (NMDAR), such as phencyclidine (PCP) and ketamine, transiently induce symptoms of acute schizophrenia had led to a paradigm shift from dopaminergic to glutamatergic dysfunction in pharmacological models of schizophrenia. The glutamate hypothesis can explain negative and cognitive symptoms of schizophrenia better than the dopamine hypothesis, and has the potential to explain dopamine dysfunction itself. The pharmacological and psychomimetic effects of ketamine, which is safer for human subjects than phencyclidine, are herein reviewed. Ketamine binds to a variety of receptors, but principally acts at the NMDAR, and convergent genetic and molecular evidence point to NMDAR hypofunction in schizophrenia. Furthermore, NMDAR hypofunction can explain connectional and oscillatory abnormalities in schizophrenia in terms of both weakened excitation of inhibitory γ-aminobutyric acidergic (GABAergic) interneurons that synchronize cortical networks and disinhibition of principal cells. Individuals with prenatal NMDAR aberrations might experience the onset of schizophrenia towards the completion of synaptic pruning in adolescence, when network connectivity drops below a critical value. We conclude that ketamine challenge is useful for studying the positive, negative, and cognitive symptoms, dopaminergic and GABAergic dysfunction, age of onset, functional dysconnectivity, and abnormal cortical oscillations observed in acute schizophrenia.

Additional Material
1 File (183.402kB)
Frohlich-JPsychopharmacol2014-fig1.jpg (183.402kB)